Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT2 Inhibitor”

396 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 396 results

Testing effectiveness (Phase 2)UnknownNCT06341842
What this trial is testing

Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity

Who this might be right for
Breast Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 316
Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Post-approval studies (Phase 4)UnknownNCT03573102
What this trial is testing

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Who this might be right for
Diabetic Nephropathies
Nahla H Tohami 60
Testing effectiveness (Phase 2)Study completedNCT03190694
What this trial is testing

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

Who this might be right for
Chronic Kidney DiseasesProteinuria
Hiddo Lambers Heerspink 53
Not applicableStudy completedNCT03717207
What this trial is testing

Cardiac Autonomic Dysfunction in Diabetics Patients With Syncope

Who this might be right for
Syncope, Vasovagal
University of Campania Luigi Vanvitelli 242
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Testing effectiveness (Phase 2)Looking for participantsNCT07336797
What this trial is testing

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Who this might be right for
Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud 66
Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Not applicableLooking for participantsNCT06283420
What this trial is testing

Metabolic Response to the Initiation of Heart Failure Therapy

Who this might be right for
Heart Failure
Vojtech Melenovsky, MD, PhD 120
Testing effectiveness (Phase 2)Looking for participantsNCT06887062
What this trial is testing

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Who this might be right for
Large Vessel VasculitisGiant Cell Arteritis (GCA)Takayasu Arteritis
University of Edinburgh 60
Testing effectiveness (Phase 2)Study completedNCT03922750
What this trial is testing

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 154
Not applicableStudy completedNCT06797115
What this trial is testing

Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes

Who this might be right for
T2DM
University of Pecs 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07488689
What this trial is testing

Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction

Who this might be right for
Septic Shock
University Hospital, Strasbourg, France 568
Post-approval studies (Phase 4)Not Yet RecruitingNCT07351864
What this trial is testing

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Who this might be right for
Heart Failure
Mansoura University 60
Post-approval studies (Phase 4)Study completedNCT02920918
What this trial is testing

Treatment of Diabetes in Patients With Systolic Heart Failure

Who this might be right for
Heart Failure, SystolicDiabetes Mellitus, Type 2
Virginia Commonwealth University 36
Large-scale testing (Phase 3)Study completedNCT05606913
What this trial is testing

IBI362 in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Innovent Biologics (Suzhou) Co. Ltd. 731
Testing effectiveness (Phase 2)Study completedNCT05757791
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
NYU Langone Health 20
Post-approval studies (Phase 4)Study completedNCT05857085
What this trial is testing

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

Who this might be right for
Endothelial DysfunctionDiabetes Mellitus, Type 1Biomarkers+7 more
General and Teaching Hospital Celje 90
Not applicableUnknownNCT05333159
What this trial is testing

The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.

Who this might be right for
Coronary Artery DiseaseDiabete Mellitus
Beijing Anzhen Hospital 1,424
Not applicableUnknownNCT06128096
What this trial is testing

The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)

Who this might be right for
Coronary Artery Disease
Clinical Research Centre, Malaysia 360
Next Page